Nabriva Therapeutics and Sinovant Sciences Restructure License Agreement for XENLETA for Community-Acquired Bacterial Pneumonia in China by Seini Moimoi | Dec 7, 2020 | Uncategorized
Sierra Oncology Strengthens Management Team to Implement North American Pre-Commercialization Strategy for Momelotinib by Seini Moimoi | Aug 6, 2020 | Uncategorized
89bio Initiates Phase 1b/2a Proof of Concept Clinical Trial of Investigational Therapy BIO89-100 for the Treatment of NASH by Seini Moimoi | Aug 8, 2019 | Uncategorized
Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO™ to Treat Complicated Urinary Tract Infections by FDA by Seini Moimoi | Jan 4, 2019 | Uncategorized
Velicept Therapeutics Raises an Additional $15 Million in Series B Round, Initiates Phase 2b Study Evaluating Once Daily Dosing of Solabegron in Patients with Overactive Bladder (OAB) and Receives Issuance of Additional U.S. Patent by Seini Moimoi | Oct 16, 2018 | Uncategorized
